The rise of Viagra and its influence on the medicinal landscape presents a complicated question for investors. While the early sales data were impressive, the exclusivity has expired, leading to a deluge of copycat https://saulimgx006262.blogsmine.com/41707133/the-blue-pill-and-big-pharma-a-risky-investment